ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "microbiome"

  • Abstract Number: 2622 • ACR Convergence 2025

    Oral Microbiome Dysbiosis and Oral-gut Microbial Network Disruption in Hand Osteoarthritis: Data from the Xiangya Osteoarthritis Study

    Jiatian Li1, Yadan Xiao2, Tuo Yang1, david Hunter3, Weiya Zhang4, Michael Doherty4, Yuqing Zhang5, Zidan Yang1, Yilun Wang1, Dongxing Xie1, Changjun Li1, Wei Li1, Zeqin Wen1, Chao Zeng1, Guanghua Lei1 and Jie Wei1, 1Xiangya Hospital, Central South University, Changsha, Hunan, China (People's Republic), 2Xiangya School of Public Health, Central South University, Changsha, Hunan, China (People's Republic), 3Sydney Musculoskeletal Health, University of Sydney, St Leonards, New South Wales, Australia, 4School of Medicine, University of Nottingham, Nottingham, United Kingdom, 5Massachusetts General Hospital, Quincy, MA

    Background/Purpose: The oral microbiome plays a critical role in modulating systemic inflammation and maintaining immune homeostasis, partly through its interactions with the gut microbiome. Although…
  • Abstract Number: 1119 • ACR Convergence 2025

    Microbial activation of cytotoxic CD8⁺ T cells promotes skin immune-related adverse events in patients treated with immune checkpoint inhibitors

    Shady Younis1, Suman Acharya1, Gayathri Swaminathan1, Heidi Wong1, Hannah Kim1, Alec Eschholz1, Subramanya Hegde2, Andrew McKnight3, William Robinson4 and Lisa Zaba1, 1Stanford University, Stanford, CA, 2Sanofi US, New Jersey, MA, 3Sanofi US, Cambridge, MA, 4Stanford University, Palo Alto, CA

    Background/Purpose: Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their use is often limited by immune-related adverse events (irAEs), particularly in barrier tissues such…
  • Abstract Number: 0101 • ACR Convergence 2025

    Enrichment of putative bacteria-reactive gut-derived IL-17+ tissue resident memory helper T cells in arthritic ankles in the SKG mouse model of spondyloarthritis

    Benjamin Cai1, Megan Soon2, Zewen Kelvin Tuong2, Mark Morrison2, Anne-Sophie Bergot3 and Ranjeny Thomas4, 1Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia, 2Frazer Institute, The University of Queensland, Brisbane, Australia, 3Frazer Institute, The University of Queensland, Woolloongabba, Queensland, Australia, 4Frazer Institute, University of Queensland, Brisbane, Queensland, Australia

    Background/Purpose: In spondyloarthropathy (SpA), arthritis is often associated with gut inflammation. The strong genetic association with HLA-B27 implicates involvement of T cells, but how gut…
  • Abstract Number: 2590 • ACR Convergence 2025

    Translating findings on urate-metabolizing bacterial genes and urate levels at the human population level: a gut microbiome analysis of three independent cohorts of men and women

    Sharan Rai1, Natalie McCormick2, Xochitl Morgan3, Matthew Nayor4, Robert Terkeltaub5, Dylan Dodd6, Lama Nazzal7, Huilin Li7, Gary Curhan8, Curtis Huttenhower3 and Hyon K. Choi9, 1Massachusetts General Hospital/Harvard Medical School, Boston, MA, 2Massachusetts General Hospital, Boston, MA, 3Harvard T.H. Chan School of Public Health, Boston, 4Boston University, Boston, 5Retired, San Diego, CA, 6Stanford University, Palo Alto, CA, 7NYU Langone, New York, NY, 8Brigham and Women's Hospital, Boston, 9MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA

    Background/Purpose: Approximately 21% of US adults have hyperuricemia, the causal precursor for gout. Human cells do not degrade urate (due to uricase gene inactivation). However,…
  • Abstract Number: 1032 • ACR Convergence 2025

    Exploring the role of the gut microbiome in gout: Prospective analysis of dietary fiber intake and the risk of gout

    Sharan Rai1, Natalie McCormick2, Chio Yokose3, Robert Terkeltaub4, Dylan Dodd5, Lama Nazzal6, Huilin Li6, Qi Sun7 and Hyon K. Choi8, 1Massachusetts General Hospital/Harvard Medical School, Boston, MA, 2Massachusetts General Hospital, Boston, MA, 3Massachusetts General Hospital, Waltham, MA, 4Retired, San Diego, CA, 5Stanford University, Palo Alto, CA, 6NYU Langone, New York, NY, 7Harvard T.H. Chan School of Public Health, Boston, 8MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA

    Background/Purpose: The role of the gut microbiome has been increasingly implicated in the pathogenesis of gout. For instance, gout patients have shown depletions of bacteria…
  • Abstract Number: 0088 • ACR Convergence 2025

    Imbalance of Inflammation-Regulating Microorganisms and Predicted Metabolomic Pathways Associates With Disease Evolution in Individuals At-Risk for Rheumatoid Arthritis

    Lyndsey Cole1, Brendan Allen2, Sucai Liu2, Marie Feser3, Le Yi Phyo2, LauraKay Moss2, Daniel Frank2, J. Kirk Harris2, Kristen Demoruelle4, Kevin Deane5, V. Michael Holers6 and Kristine Kuhn7, 1University of Colorado School of Medicine, Centennial, CO, 2University of Colorado School of Medicine, Aurora, CO, 3University of Colorado Anschutz Medical Campus, Aurora, CO, 4University of Colorado Anschutz Medical Campus, Golden, CO, 5University of Colorado Denver Anschutz Medical Campus, Aurora, CO, 6University of Colorado Anschutz Medical Campus, Aurora, 72022 - 2023 / Adult/ University of Colorado, Aurora, CO

    Background/Purpose: The mucosal origins hypothesis of RA proposes that immune responses to microorganisms at mucosal sites (e.g. intestine) lead to systemic inflammation and autoimmunity. Little…
  • Abstract Number: 2589 • ACR Convergence 2025

    Multi-omics Integration Reveals Gut Microbiota–Metabolite Dysregulation in Gout with Metabolic Syndrome

    Yuanpiao Ni1, Fanxin Zeng2, Yufeng Qing3 and Quanbo Zhang3, 1Affiliated Hospital Of North Sichuan Medical College, Nanchong, Sichuan, China (People's Republic), 2Dazhou Central Hospital, Dazhou, Sichuan, China (People's Republic), 3The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China (People's Republic)

    Background/Purpose: Gout is a metabolic disorder driven by abnormalities in urate metabolism and chronic inflammation. Recent studies suggest that gout is not limited to joint…
  • Abstract Number: 0938 • ACR Convergence 2025

    Short Term Antibiotic Treatment Improves the Neurobehavioral Phenotype of MRL/lpr Mice

    Melodie Zaknoun1, Doaa Tehawey1, Baruh Polis1 and Chaim Putterman2, 1Azrieli Faculty of Medicine, Safed, Israel, 2Albert Einstein College of Medicine, Safed, Israel

    Background/Purpose: Neuropsychiatric lupus (NPSLE) is a common and prognostically significant manifestation of SLE, affecting 20-40% of lupus patients. The ACR identified 19 clinical syndromes associated…
  • Abstract Number: 0054 • ACR Convergence 2025

    Microbial Cues Promote Arthritis and Alter T Cell Selection in SKG Mice

    Astha Patel1, Steven yu1, Yuka Nakao1, Mohana Mukherjee1, Diego Orellana2, Jose Scher3, Peter Turnbaugh1, Renuka Nayak4 and Judith Ashouri1, 1University of California, San Francisco, San Francisco, CA, 2University of California San Francisco, San Francisco, CA, 3New York University School of Medicine, New York, NY, 4University of California, San Francisco (UCSF), San Francisco, CA

    Background/Purpose: Dysbiosis of the gut microbiota has been linked to rheumatoid arthritis (RA), but it remains unclear whether these microbial alterations are causal or secondary…
  • Abstract Number: 1585 • ACR Convergence 2024

    Characterization of the Fecal Metabolome in Early Systemic Sclerosis

    Arissa Young1, Kristofer Andreasson2, Jen Labus3, Nedas Matulianos4, Blake Wilde1, Jonathan Jacobs3, Heather Christofk4 and Elizabeth Volkmann5, 1UCLA, Los Angeles, CA, 2Lund University, Lund, Sweden, 3UCLA, Los Angeles, 4University of California Los Angeles, Los Angeles, CA, 5University of California, Department of Medicine, Los Angeles, CA, USA, Los Angeles

    Background/Purpose: Previous studies have shown that alterations in gut microbiota are present early in systemic sclerosis (SSc) (Andréasson et al. 2022) and are associated with…
  • Abstract Number: 1708 • ACR Convergence 2024

    Unveiling the Uterine-Joint Axis: Dysbiosis and Subclinical Uterine Inflammation in Female Axial Spondyloarthritis Pathogenesis

    Daniele Mauro1, Matteo Vecellio2, Anne-Sophie Bergot3, Eva Schmid4, Giulio Forte5, Alessia Stingo6, Alessia Salzillo5, Aldo Pastore7, Paolo Aretini7, Francesca Di Lorenzo7, Antonio ciancio5, Ilenia Pantano5, Gabriele Saccone8, Fulvio Zullo9, carlo Maurizio Montecucco10, Aroldo Rizzo11, Georg Schett12, Ranjeny Thomas13, Mario Zaiss14 and Francesco Ciccia15, 1University of Campania, Italy, Naples, Naples, Italy, 2Fondazione Pisana per la Scienza ONLUS, Pisa, Italy, 3Frazer Institute, University of Queensland, Brisbane, Australia, 4Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Rheumatology and Immunology, Erlangen, Erlangen, Germany, 5University of Campania L. Vanvitelli, Naples, Italy, 6University of Campania L. Vanvitelli, Nasples, Italy, 7Fondazione Pisana per la Scienza ONLUS, Giuliano Terme, Italy, 8University Federico II of Naples, Naples, Italy, 9University of Catanzaro, Catanzaro, Italy, 10Unit of Rheumatology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy, 11Azienda Ospedaliera Ospedali riuniti Villa Sofia Cervello,, Palermo, Italy, 12Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, 13University of Queensland, Brisbane, Australia, 14Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universittsklinikum Erlangen, Erlangen, Germany; 2 Deutsches Zentrum für Immuntherapie (DZI), Erlangen, Germany, 15Università degli studi della Campania Luigi Vanvitelli, Naples, Italy

    Background/Purpose: Numerous studies exploring gender differences in axial spondyloarthritis (AxSpA) have noted that women exhibit distinct disease manifestations. Yet, a definitive pathophysiological distinction of these diverse…
  • Abstract Number: 0012 • ACR Convergence 2024

    Dichotomous Expression of CXCR3 and CCR9 and Relationship to Intestinal Permeability in B Cells in Rheumatoid Arthritis

    Ken Yasaka, Ruoqiao Wang, Nida Pellett, Daria Krenitsky, Juilee Thakar and Jennifer Anolik, University of Rochester Medical Center, Rochester, NY

    Background/Purpose: The gut is a key mucosal tissue that can impact the immune system and contribute to systemic inflammation in the setting of increased intestinal…
  • Abstract Number: 1851 • ACR Convergence 2024

    Aberrant Tfh Cells Generated by Th17 Cell Plasticity in the Gut Promote Autoimmune Arthritis

    Joyce Wu, The Ohio State University, Columbus, OH

    Background/Purpose: Much remains unknown regarding T follicular helper 17 (Tfh17) cells in autoimmunity. We previously showed, and here ask why, egress of gut segmented filamentous…
  • Abstract Number: 0034 • ACR Convergence 2024

    Arthritogenic Subdoligranulum (S. Dido 7) Is Increased in Individuals At-Risk for and with Early RA and Decreases over Time During Development of Inflammatory Arthritis

    Lyndsey Cole1, Sucai Liu2, Brendan Allen2, Marie Feser3, Kristen Demoruelle4, Kevin Deane5, Michael Holers3 and Kristine Kuhn6, 1University of Colorado School of Medicine, Centennial, CO, 2University of Colorado School of Medicine, Aurora, CO, 3Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 4University of Colorado Anschutz Medical Campus, Golden, CO, 5University of Colorado Denver Anschutz Medical Campus, Aurora, CO, 6University of Colorado, Aurora, CO

    Background/Purpose: Subdoligranulum didolesgii, S. dido 7, is present in a subset of individuals who are at-risk for RA (termed ‘ARI’) and who have clinical RA,…
  • Abstract Number: 2092 • ACR Convergence 2024

    Remote-Delivered Tai Chi and Gut Microbiota in Osteoarthritis: A Randomized Mechanistic Trial

    Chenchen Wang1, Timothy McAlindon2, Meghan Short1, Mei Chung3, Ye Chen1, Albert Tai1 and Honorine Ward1, 1Tufts Medical Center, Boston, MA, 2University of Massachusets, Worchester, MA, 3Tufts Medical Center, Brighton, MA

    Background/Purpose: Previous studies show that Tai Chi achieves clinical improvement for osteoarthritis (OA) through multiple pathways. There is evidence for interaction of the gut microbiota…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology